Correlation Between Pfizer and 456837AQ6
Specify exactly 2 symbols:
By analyzing existing cross correlation between Pfizer Inc and ING GROEP NV, you can compare the effects of market volatilities on Pfizer and 456837AQ6 and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of 456837AQ6. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and 456837AQ6.
Diversification Opportunities for Pfizer and 456837AQ6
Pay attention - limited upside
The 3 months correlation between Pfizer and 456837AQ6 is -0.79. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and ING GROEP NV in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ING GROEP NV and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with 456837AQ6. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ING GROEP NV has no effect on the direction of Pfizer i.e., Pfizer and 456837AQ6 go up and down completely randomly.
Pair Corralation between Pfizer and 456837AQ6
Considering the 90-day investment horizon Pfizer Inc is expected to generate 3.36 times more return on investment than 456837AQ6. However, Pfizer is 3.36 times more volatile than ING GROEP NV. It trades about 0.05 of its potential returns per unit of risk. ING GROEP NV is currently generating about -0.19 per unit of risk. If you would invest 2,565 in Pfizer Inc on October 23, 2024 and sell it today you would earn a total of 65.00 from holding Pfizer Inc or generate 2.53% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 81.58% |
| Values | Daily Returns |
Pfizer Inc vs. ING GROEP NV
Performance |
| Timeline |
| Pfizer Inc |
| ING GROEP NV |
Pfizer and 456837AQ6 Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Pfizer and 456837AQ6
The main advantage of trading using opposite Pfizer and 456837AQ6 positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, 456837AQ6 can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 456837AQ6 will offset losses from the drop in 456837AQ6's long position.| Pfizer vs. DiaMedica Therapeutics | Pfizer vs. Seres Therapeutics | Pfizer vs. Inhibikase Therapeutics | Pfizer vs. Oncolytics Biotech |
| 456837AQ6 vs. Playa Hotels Resorts | 456837AQ6 vs. Teradyne | 456837AQ6 vs. Taiwan Semiconductor Manufacturing | 456837AQ6 vs. BE Semiconductor Industries |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Other Complementary Tools
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |